Junior Recital: Lorin Green, flute and piccolo

This recital is presented in partial fulfillment of requirements for the degree Bachelor of Music in Performance. Ms. Green studies flute with Christina Smith and piccolo with Kelly Bryant.https://digitalcommons.kennesaw.edu/musicprograms/2149/thumbnail.jp

Women\u27s Choir with Lost Mountain Middle School 7th and 8th Grade Choruses

The KSU Women\u27s Choir, directed by Dr. Alison Mann, Associate Professor of Choral Music Education, and the Lost Mountain Middle School Choruses present a performance titled I Carry Your Heart With Me.https://digitalcommons.kennesaw.edu/musicprograms/2170/thumbnail.jp

Junior Recital: Michael S. Brown Jr, trumpet

This recital is presented in partial fulfillment of requirements for the degree Bachelor of Music in Performance. Mr. Brown studies trumpet with Douglas Lindsey.https://digitalcommons.kennesaw.edu/musicprograms/2228/thumbnail.jp

Senior Recital: Chris Marks

Senior Recital: Chris Markshttps://digitalcommons.kennesaw.edu/musicprograms/2444/thumbnail.jp

Senior Recital: Lorin Green Flute / Piccolo

This recital is presented in partial fulfillment of requirements for the degree Bachelor of Music in Performance. Ms. Green studies Flute with Christina Smith and Kelly Bryant.https://digitalcommons.kennesaw.edu/musicprograms/2249/thumbnail.jp

Chemoprevention of Colonic Polyps with Balsalazide: An Exploratory, Double-Blind, Placebo-Controlled Study

A number of agents, including aspirin, nonsteroidal antiinflammatory drugs, cyclooxygenase-2 inhibitors, folic acid, calcium, and vitamins, have been evaluated for their potential in chemoprevention of sporadic colorectal adenomas or cancer. Preclinical data suggest that 5-aminosalicylates also may have a chemopreventive effect. To investigate chemoprevention of colonic polyps with balsalazide, a 5-aminosalicylate prodrug. In this randomized, double-blind, placebo-controlled study, adults diagnosed with small polyps in the rectosigmoid colon were treated with either balsalazide 3 g/d or placebo for 6 months. Follow-up lower endoscopy was performed, and all polyps were measured and analyzed histologically. The primary endpoint was reduction in mean size of the largest polyp per subject. Among 241 participants screened, 86 were randomized to treatment, with 75 subjects evaluable. Balsalazide 3 g/d (n = 38) did not significantly reduce the mean size of the largest colonic polyp or the number of polyps compared with placebo (n = 37). Although not significant, post-hoc analysis revealed that total adenoma burden per subject, calculated as the sum of the volumes of all adenomas in mm3, increased by 55% in the balsalazide group compared with 95% in the placebo group. Although balsalazide did not have significant chemopreventive effects on established colonic polyps, these results can aid in designing future prospective studies

Multidrug-Resistant Salmonella Typhimurium, Pacific Northwest, United States

We compared human and bovine isolates of Salmonella enterica using antimicrobial-drug resistance profiles and pulsed-field gel electrophoresis. From 2000 through 2006, we observed an increase in a novel multidrug-resistant clone of S . Typhimurium with no recognized phage type. This clone may represent an emerging epidemic strain in the Pacific Northwest